Ecovyst

ECVT on NYSE. Ecovyst sells sulfuric acid products and services to industrial customers. Market value $1.2bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Worth a closer look

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
past 12 months to September 2026
2.7%low

For every $100 of what the whole company costs, it produced $2.74 of spare cash in the past 12 months. A savings account pays about $4.

Price to profit
past 12 months to September 2026
16.9×full

You pay 16.9 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
4.7%five-year median

Each dollar kept in the business earns 5 cents a year. Above 10 is good.

Quality score: 83 of 100. Price score: 60 of 100. Our list needs 70 on quality and 60 on price.

$9.00 a share, 10% above its 1-year low

Over the past year the price has ranged from $8.20 to $15.09.

Pays no dividend

Prices from Friday’s close (20 November).

Five years of cash, in billions

0.1
0.1
0.1
0.1
0.1
0.0
2021202220232024202512 monthsto Sep '26

Spare cash swings from quarter to quarter here: $27 million in the past 12 months, $70 million in the year to December 2025.

Revenue
$611m$820m$585m$598m$724m
Operating margin
8.9%12.7%15.3%14.2%9.0%
Debt to equity
1.211.251.241.240.65
Shares outstanding
0.13bn0.12bn0.12bn0.11bn0.11bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)6 of 9
  • Profit backed by cash (accruals)No
  • Debt0.65× equity
  • Revenue growth, five yearsSlow, 7.8% a year
  • Buying back its own sharesYes, 17% fewer since 2021

The quarter to September 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $309 million last quarter, up 51% on a year ago.
  • Profit: $18 million, after a loss of $79 million a year ago.
  • It keeps 9 cents of each $1 of sales as operating profit, down from 10 cents a year earlier.
  • Spare cash over the past 12 months: $27 million, down from $78 million.
  • 4% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $422 million more than cash, down from $773 million a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
December 2024$149m
March 2025$143m
June 2025$176m
September 2025$205m
December 2025$199m
March 2026$215m
June 2026$250m
September 2026$309m
Profit by quarter
Profit by quarter
Quarter toAmount
December 2024-$30m
March 2025-$4m
June 2025$6m
September 2025-$79m
December 2025$6m
March 2026$4m
June 2026$8m
September 2026$18m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
n/a
Last annual report (10-K)
27 February 2026
Next quarterly (estimated, 10-Q)
4 February 2027

Who owns it

4 long-term investors we follow own it, unchanged from 4 last quarter. 209 funds in all.

Jun '25
Dec '25
Jun '26

Sold out this quarter

Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

6 investors own more than 5%.

  • at least 9.1%
    (filed with 1 related holder)
    Since 30 September 2025
  • FMR LLC
    Passive investor
    at least 7.7%
    (filed with 1 related holder)
    Since 30 September 2026
  • BlackRock, Inc.
    Passive investor
    7.7%
    Since 31 March 2026
  • 6.0%
    Since 30 June 2026
  • 5.7%
    Since 30 June 2026
  • 5.3%
    Since 31 March 2026
  • Hotchkis & Wiley
    Passive investor
    Sold down below 5%
    Since 31 March 2026
  • The Vanguard Group
    Passive investor
    Sold down below 5%
    Since 13 March 2026
  • INEOS Limited
    Sold down below 5%
    Since 30 June 2025
    What they said

    Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following: On June 30, 2025, INEOS sold 9,040,415 shares of Common Stock in a private transaction to a broker-dealer at a price per share of $7.60. As a result of such sale, the Reporting…

    Read the filing

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 1 insider bought $249,994 of shares on the open market. 1 sold $112,639.

  • Humble Patti A.
    Director
    Bought
    Date
    10 September 2026
    Shares
    24,875
    Price
    $10.05
    Value
    $249,994
  • Lorance Sarah
    Director
    Sold
    Date
    2 June 2026
    Shares
    8,450
    Price
    $13.33
    Value
    $112,639

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 27 Feb 2026, plus the 10-Q filed 5 Nov 2026 and 9 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

What changed in the risks this year

Companies must list what could hurt them each year. These are the parts that changed since last year’s report.

  • Our use of artificial intelligence (“AI”) and other emerging technologies could adversely impact our business and financial results.

    Could happen
    We have begun to deploy AI and other emerging technologies in various facets of our operations, and we continue to explore further use cases. The rapid advancement of these technologies presents opportunities for us in research, manufacturing, commercialization, and other business endeavors, but also entails risks, including that AI-generated content, analyses, or recommendations we utilize could be deficient, that our competitors may more quickly or effectively adopt AI capabilities, or that our use of AI or other emerging technologies increases regulatory, privacy, cybersecurity and other significant risks. In addition, any disruption or failure in the AI functionality we incorporate into our business activities, products or services could adversely impact our business. The legal and regulatory landscape surrounding AI technologies is rapidly evolving and uncertain, including in the areas of intellectual property, cybersecurity and privacy and data protection. Compliance with new or changing laws, regulations or industry standards relating to AI may impose significant costs on us and limit our ability to effectively develop, deploy or use AI technologies. Furthermore, if we are unable to effectively manage the use of AI technologies by our employees and service providers, our confidential information, intellectual property and reputation could be put at risk. Failure to appropriately respond to this evolving landscape may result in reputational, competitive and business harm as well as litigation and regulatory action and fines, penalties and expenses related thereto.
    Read more
  • We may be subject to future changes in tax legislation or exposure to additional tax liabilities that may adversely affect our results of operations.

    Could happen
    We are subject to taxes in the U.S. where our subsidiaries are organized. Due to economic and political conditions, tax rates, tax laws and other non-tax legislation, such as economic substance regulations, our business may experience significant impacts as a result of prospective changes. For example, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. on July 4, 2025, which includes significant changes to U.S. tax rules and will be further implemented through the promulgation of regulations and publishing official guidance. These changes include the immediate expensing of domestic research and development expenditures, the reinstatement of 100% bonus depreciation on qualified property, a change in the limitation on the deduction of business interest expense and changes to the taxation in respect of the income earned by our non-U.S. subsidiaries among other changes. We have recognized the effects of the OBBBA provisions in our financial results to the extent they are applicable to the year ended December 31, 2025. We will continue to evaluate the impact of these provisions. Our future effective tax rates may be affected by changes in the valuation of deferred tax assets and liabilities, changes in available tax credits or tax deductions, as well as changes in tax and other non-tax laws or their interpretation.
    Read more
  • We may engage in strategic acquisitions or dispositions of certain assets or businesses that could affect our business, results of operations, financial condition and liquidity.

    Could happen
    We may also opportunistically pursue dispositions of certain assets and businesses, which may involve material amounts of assets or lines of business, which could adversely affect our results of operations, financial condition and liquidity. For instance, effective on December 31, 2025, we completed the sale of our Advanced Materials & Catalysts segment, which includes the Zeolyst Joint Venture, to Technip Energies N.V. for a purchase price of $556.0 million, subject to certain adjustments set forth in the agreement.
    Read more

Read it in the annual report

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

It just passed both our tests. The deep dive checks what the numbers can't.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.